Cargando…
Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report
Endometrial cancer (EC) is the 4th most common neoplasm of the female genital tract, with 15–20% of patients being of high risk of recurrence which leads to a significant decrease in patient survival. Current therapeutic options for patients with EC are poor, being the combined therapy of carboplati...
Autores principales: | Casas-Arozamena, Carlos, Cortegoso, Alexandra, Piñeiro-Perez, Raquel, Abalo, Alicia, Arias, Efigenia, Sampayo, Victoria, Vilar, Ana, Bouso, Marta, Diaz, Eva, Moreno-Bueno, Gema, López-López, Rafael, Muinelo-Romay, Laura, Abal, Miguel, Cueva, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369153/ https://www.ncbi.nlm.nih.gov/pubmed/35955673 http://dx.doi.org/10.3390/ijms23158539 |
Ejemplares similares
-
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020) -
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018) -
Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019) -
Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022) -
Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)